ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Programmable DNA/Polyacrylamide Network-Grafted Broadband Plasmonic Liquid Metal Nanoparticles for Ultrafast Real-Time Molecular Diagnostics.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Gallium-based room-temperature liquid metals (LMs) combine the desirable properties of metals and liquids, and possess highly reactive surfaces, emerging as a promising component in constructing smart soft composites for various applications, particularly in biosensing and diagnostics. Herein, we report on the development of an ultrafast, real-time molecular diagnostic platform based on gallium-based LM nanoparticles (LM NPs) grafted with programmable DNA/polyacrylamide networks. LM NPs with strong and broadband plasmonic light absorption are demonstrated as efficient photothermal agents to enable stable temperature cycles, and the LM surface-initiated polymerization reaction allows direct grafting of DNA/polyacrylamide copolymer networks onto LM NPs, yielding core-shell nanocomposites with significantly enhanced photothermal stability and capable of participating in enzymatic amplification reactions. Thanks to the efficient cascading of the photothermal process and the PCR-based amplification process, real-time detection of nucleic acid targets within 6.5 min is achieved, and the testing of different viral and bacterial targets with high sensitivity and specificity is achieved. The broadband light absorption of LM NPs also allows the molecular diagnostic platform works under portable LED devices, such as a LED flashlight, which can be further developed into low-cost, rapid POCT molecular diagnostic devices for practical disease diagnosis and other applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.